Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for NURIX THERAPEUTICS INC, €120k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Christine Ring: trading record in brief
Christine Ring discloses dealings in Nurix Therapeutics, Inc. to SEC (Form 4). Between 2 June 2026 and 2 October 2026, the trades on record add up to 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 October 2026, the filings show a transaction worth €120k in Nurix Therapeutics, Inc. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christine Ring
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
5,786 shares@ US$23.34CommonSEC144:0001950047-26-010001
16,589 shares@ US$23.210.016% mcap35.2% of flowCommonSEC144:0001950047-26-007550
11,008 shares@ US$23.910.011% mcap100.0% of flowCommonSEC144:0001950047-26-006819
28,935 shares@ US$19.3051.9% of flowCommonSEC144:0001950047-26-006501
8,148 shares@ US$17.3912.9% of flowCommonSEC144:0001950047-26-005496
5 of 5 declarations
